Company news

Cyclerion Therapeutics, Inc. news in 2020

Cyclerion Therapeutics, Inc.'s news releases, calls and decks from 2020, newest first.

View company

Cyclerion Announces Leadership Transitions

December 20, 2020

Cyclerion Therapeutics Reports Third Quarter 2020 Financial Results and Recent Corporate Updates

November 4, 2020

Cyclerion Announces Positive Data from IW-6463 CNS Translational Pharmacology Study in Healthy Elderly Subjects

October 13, 2020

Cyclerion Announces Phase 2 STRONG-SCD Study Results in Patients with Sickle Cell Disease

October 13, 2020

Cyclerion Announces Translational Research Award from the Alzheimer’s Association Part the Cloud-Gates Partnership Grant Program

August 24, 2020

Cyclerion Therapeutics Reports Second Quarter 2020 Financial Results and Recent Corporate Highlights

August 2, 2020

Cyclerion Therapeutics Completes $24 Million Private Placement

July 29, 2020

Cyclerion Updates Corporate Progress

April 9, 2020

Cyclerion announces IW-6463 phase 1 healthy volunteer study results that support further development for neurodegenerative diseases

January 12, 2020

Decks in 2020